A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT06150560
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose supportive care
- Phase
- Phase 3
- Enrolled
- 120 participants
- Registry
-
NCT06150560
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06150560. Randomized; double masking; primary purpose supportive care. Start 2024-04-01 (actual); primary completion 2028-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
- Acronym
- VALUE
- Condition
- Coarctation of Aorta
- Condition
- High Blood Pressure
- Intervention (Drug)
- Losartan
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Mayo Clinic
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct06150560- Content hash
eda64a17359840687359cddce3ff3d4773f620972fbe509b7c9dfaec3164c75d